Postoperative Nausea and Vomiting Clinical Trial
Official title:
Osteopathic Manipulative Treatment (OMT) as Possible Prophylaxis Against Post-Operative Nausea and Vomiting (PONV) in Patients Receiving Inhalational Anesthesia
The purpose of this study is to determine if Osteopathic Manipulative Treatment (OMT) is
effective in reducing nausea and vomiting experienced by patients recovering from
anesthesia. OMT is a treatment in which the physician places his hands on areas of the body
and applies pressure to correct disturbances in one area that may be related to a problem in
another area of the body. Osteopathic Manipulative Medicine is a specialty for a physician
who uses OMT.
The hypothesis of this study is when OMT is combined with standard-of-care prophylactic
anti-emetic therapy in patients following administration of inhalational anesthesia, in
comparison to a control group receiving only standard-of-care anti-emetic prophylaxis there
will be a reduction in the incidence and severity of PONV.
This research study is a prospective, randomized, single-blinded, controlled, clinical trial
under the principal investigator, Hollis King, DO, PhD with the University of North Texas -
Health Science Center, Texas College of Osteopathic Medicine. The purpose of this study is
to determine the effectiveness of osteopathic manipulative treatment (OMT) as an adjunctive
modality to standard medical care for reduction of post-operative nausea and vomiting
(PONV). This is the first attempt to study the treatment of PONV utilizing OMM; this study
is being conducted as a pilot study
The hypothesis of this study is when OMT is combined with standard-of-care prophylactic
anti-emetic therapy in patients following administration of inhalational anesthesia, in
comparison to a control group receiving only standard-of-care anti-emetic prophylaxis there
will be a reduction in the incidence and severity of PONV.
Two aims will guide this study toward evaluation of the hypothesis:
AIM I: To demonstrate the effect of OMT and standard care on the number of episodes of
emesis experienced post-operatively by subjects having undergone anesthesia utilizing
inhalational anesthesia (alone or in combination with intravenous anesthetics). All subjects
will receive the treatment or "no-treat" protocol to which they are randomized. Data will be
collected prior to discharge from the post-anesthesia care unit (PACU) to enumerate the
episodes of emesis experienced by each study subject. Subjects will be asked to complete the
Ambulatory Surgery-Rhodes Index of Nausea, Vomiting, and Retching (AS-RINVR) 24-48 hours
following surgery when a post-study questionnaire is completed.1
AIM II: To demonstrate the effect of OMT and standard care on the intensity of nausea
experienced post-operatively by subjects having undergone anesthesia utilizing inhalational
anesthesia (alone or in combination with intravenous anesthetics). Following a subject's
completion of the treatment protocol (or "no-treat" if so randomized), the nausea visual
analog scale (VAS) validated by Boogaerts will be employed at 30 minutes, 1 hour, and 24-36
hours following their post-operative, post-anesthesia treatment protocol. Results will be
compared between the control and experimental group for differences.
Osteopathic manipulative medicine (OMM) and OMT seek, in general, to facilitate a more
optimal and often faster return to health and homeostasis. Though individuals largely seek
out OMT for alleviation of structural and musculoskeletal complaints, its uses have been
speculated and discovered to have effects also on physiologic mechanisms. Osteopathic
manipulative treatment maneuvers to the head, neck, and upper thoracic spine may impart
postulated mechanisms for PONV.3 Successful treatment will be measured by the reduction of
PONV, as evaluated on several outcome measures, in a group of subjects receiving
post-operative OMT along with standard-of-care treatment over those in the control group
only receiving standard-of-care treatment for their PONV. Successful completion of all of
the above specific aims will not only validate the hypothesis of this study but will also
establish the study's effect and feasibility for future study. Additionally, this pilot
study will establish the statistical trends needed to establish effect size data which is
needed for power analysis and sample size estimates for future studies.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04466046 -
The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
|
||
| Completed |
NCT03139383 -
Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery
|
N/A | |
| Recruiting |
NCT04069806 -
Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section
|
N/A | |
| Completed |
NCT04043247 -
Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting
|
N/A | |
| Terminated |
NCT01975727 -
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
|
Phase 2 | |
| Completed |
NCT03662672 -
Rib Raising for Post-operative Ileus
|
N/A | |
| Completed |
NCT00090155 -
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
|
Phase 3 | |
| Recruiting |
NCT05375721 -
Prevention of PONV With Traditional Chinese Medicine
|
N/A | |
| Completed |
NCT02480088 -
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
|
Phase 4 | |
| Recruiting |
NCT06137027 -
Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting
|
Early Phase 1 | |
| Not yet recruiting |
NCT05529004 -
A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy
|
Phase 2 | |
| Completed |
NCT02944942 -
Risk Factors for Postoperative Nausea/Vomiting
|
N/A | |
| Recruiting |
NCT02571153 -
Low Doses of Ketamine and Postoperative Quality of Recovery
|
Phase 4 | |
| Completed |
NCT02550795 -
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
|
N/A | |
| Completed |
NCT02449291 -
Study of APD421 as PONV Treatment (no Prior Prophylaxis)
|
Phase 3 | |
| Recruiting |
NCT01442012 -
Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
|
N/A | |
| Completed |
NCT01478165 -
Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting
|
N/A | |
| Unknown status |
NCT01268748 -
Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain
|
N/A | |
| Completed |
NCT02143531 -
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
|
Phase 4 | |
| Completed |
NCT00734929 -
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
|
Phase 4 |